ARSMX | DFFVX | ARSMX / DFFVX | |
Total Expense Ratio | 1.29 | 0.29 | 445% |
Annual Report Gross Expense Ratio | 1.29 | 0.30 | 430% |
Fund Existence | 18 years | 25 years | - |
Gain YTD | 4.162 | 2.008 | 207% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2000 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 354M | 13.3B | 3% |
Annual Yield % from dividends | 0.23 | 1.63 | 14% |
Returns for 1 year | 1.33 | 3.20 | 42% |
Returns for 3 years | 13.10 | 31.44 | 42% |
Returns for 5 years | 51.49 | 105.01 | 49% |
Returns for 10 years | 31.65 | 67.93 | 47% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
FSMEX | 60.18 | 0.53 | +0.89% |
Fidelity Select Medical Tech and Devcs | |||
MSMFX | 16.27 | 0.11 | +0.68% |
Morgan Stanley Inst Discovery C | |||
VSTSX | 300.61 | 1.32 | +0.44% |
Vanguard Total Stock Mkt Idx Instl Sel | |||
MBINX | 31.56 | 0.11 | +0.35% |
NYLI Balanced Investor Class | |||
AVEWX | 22.42 | 0.05 | +0.22% |
Ave Maria World Equity |